ABEONA THERAPEUTICS® CONGRATULATES ULTRAGENYX ON U.S. FDA APPROVAL OF FAYUVI™ GENE THERAPY FOR SANFILIPPO SYNDROME TYPE A (MPS IIIA)

Reuters · 1d ago

Please log in to view news